Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.83+0.01 (+0.55%)
Close on Nov 18, 2026Market cap $568.82MP/E –Yield 0.00%
Pacific Biosciences of California free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Pacific Biosciences of California's free cash flow for the twelve months ending Jun 30, 2026 was -$123.42M. For fiscal 2025 it was -$113.92M. The highest annual figure on record is $18.46M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$113.92M | – |
| FY2024 | Dec 31, 2024 | -$212.25M | – |
| FY2023 | Dec 31, 2023 | -$268.02M | – |
| FY2022 | Dec 31, 2022 | -$279.96M | – |
| FY2021 | Dec 31, 2021 | -$117.11M | -734.3% |
| FY2020 | Dec 31, 2020 | $18.46M | – |
| FY2019 | Dec 31, 2019 | -$81.15M | – |
| FY2018 | Dec 31, 2018 | -$68.28M | – |
| FY2017 | Dec 31, 2017 | -$77.95M | – |
| FY2016 | Dec 31, 2016 | -$76.14M | – |
| FY2015 | Dec 31, 2015 | -$50.90M | – |
| FY2014 | Dec 31, 2014 | -$53.08M | – |
| FY2013 | Dec 31, 2013 | -$30.74M | – |
| FY2012 | Dec 31, 2012 | -$78.53M | – |
| FY2011 | Dec 31, 2011 | -$112.26M | – |
| FY2010 | Dec 31, 2010 | -$127.26M | – |
| FY2009 | Dec 31, 2009 | -$80.02M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$37.14M | – |
| Q1 FY2026 | Mar 31, 2026 | -$47.73M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$29.93M | – |
| Q1 FY2025 | Mar 31, 2025 | -$45.45M | – |
| Q4 FY2024 | Dec 31, 2024 | -$32.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$44.68M | – |
| Q2 FY2024 | Jun 30, 2024 | -$55.74M | – |
| Q1 FY2024 | Mar 31, 2024 | -$79.56M | – |
| Q4 FY2023 | Dec 31, 2023 | -$59.58M | – |
| Q3 FY2023 | Sep 30, 2023 | -$66.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$44.01M | – |
| Q1 FY2023 | Mar 31, 2023 | -$98.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$65.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$67.24M | – |
| Q2 FY2022 | Jun 30, 2022 | -$64.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$82.67M | – |
| Q4 FY2021 | Dec 31, 2021 | -$34.55M | – |
| Q3 FY2021 | Sep 30, 2021 | -$41.78M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$23.51M | -131.2% |
| Q4 FY2020 | Dec 31, 2020 | -$14.33M | – |
| Q3 FY2020 | Sep 30, 2020 | -$18.34M | – |
| Q2 FY2020 | Jun 30, 2020 | -$24.11M | – |
| Q1 FY2020 | Mar 31, 2020 | $75.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.32M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$18.17M | – |
| Q1 FY2019 | Mar 31, 2019 | -$26.57M | – |
| Q4 FY2018 | Dec 31, 2018 | -$19.04M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.27M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.85M | – |
| Q1 FY2018 | Mar 31, 2018 | -$19.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$21.26M | – |
| Q3 FY2017 | Sep 30, 2017 | -$21.10M | – |
| Q2 FY2017 | Jun 30, 2017 | -$16.26M | – |
| Q1 FY2017 | Mar 31, 2017 | -$19.34M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.55M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.18M | – |
See a number that looks wrong?